loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 847e8b4e 4c14 4c36 B824 5e1ab6a5db6f Applno 209501 Form Tablet Extended Release Oral Dosage 330mg - Drug Product Composition: Lyrica

    Menu

    Lyrica

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 90Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 209501 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 330MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PREGABALIN(UNII: 55JG375S6M)
    (PREGABALIN - UNII:55JG375S6M)     		PREGABALIN165mg